M

Magle Chemoswed Holding AB
STO:MAGLE

Watchlist Manager
Magle Chemoswed Holding AB
STO:MAGLE
Watchlist
Price: 34 SEK Market Closed
Market Cap: 667.4m SEK
Have any thoughts about
Magle Chemoswed Holding AB?
Write Note

Magle Chemoswed Holding AB
Other Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Magle Chemoswed Holding AB
Other Operating Expenses Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
M
Magle Chemoswed Holding AB
STO:MAGLE
Other Operating Expenses
-kr40.5m
CAGR 3-Years
-3%
CAGR 5-Years
-2%
CAGR 10-Years
N/A
AddLife AB
STO:ALIF B
Other Operating Expenses
kr230m
CAGR 3-Years
112%
CAGR 5-Years
85%
CAGR 10-Years
N/A
BICO Group AB
STO:BICO
Other Operating Expenses
kr218m
CAGR 3-Years
146%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Biotage AB
STO:BIOT
Other Operating Expenses
-kr11m
CAGR 3-Years
17%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
G
Genovis AB
STO:GENO
Other Operating Expenses
-kr748k
CAGR 3-Years
55%
CAGR 5-Years
42%
CAGR 10-Years
N/A
MedCap AB (publ)
STO:MCAP
Other Operating Expenses
kr24.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Magle Chemoswed Holding AB
Glance View

Market Cap
667.4m SEK
Industry
Life Sciences Tools & Services

Magle Chemoswed Holding AB engages in the provision of contract development and manufacturing services to the pharmaceutical and medical device industry. The company is headquartered in Malmo, Skane. The company went IPO on 2020-06-30. The firm's operations are mainly conducted through the subsidiaries Magle Chemoswed AB and Adroit Science AB. The business is focused on process development and manufacturing of Active Pharmaceutical Ingredients (API) as well as research, development and manufacturing of products in the areas of wound care and diagnostics with particular focus on products based on degradables starch microspheres. Magle Chemoswed also functions as a consultancy in material characterization and solid phase analysis with a main focus on pharmaceutical companies.

MAGLE Intrinsic Value
85.22 SEK
Undervaluation 60%
Intrinsic Value
Price
M

See Also

What is Magle Chemoswed Holding AB's Other Operating Expenses?
Other Operating Expenses
-40.5m SEK

Based on the financial report for Dec 31, 2023, Magle Chemoswed Holding AB's Other Operating Expenses amounts to -40.5m SEK.

What is Magle Chemoswed Holding AB's Other Operating Expenses growth rate?
Other Operating Expenses CAGR 5Y
-2%

Over the last year, the Other Operating Expenses growth was 7%. The average annual Other Operating Expenses growth rates for Magle Chemoswed Holding AB have been -3% over the past three years , -2% over the past five years .

Back to Top